Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
TEVA

Teva

, AGN

Allergan

$245.71

-0.02 (-0.01%)

12:55
07/19/17
07/19
12:55
07/19/17
12:55
Conference/Events
Piper Jaffray specialty pharma analysts hold an analyst/industry conference call »

Specialty Pharmaceuticals…

TEVA

Teva

AGN

Allergan

$245.71

-0.02 (-0.01%)

SUPN

Supernus

$43.05

1.1 (2.62%)

ALDR

Alder Biopharmaceuticals

$11.55

-0.3 (-2.53%)

AMGN

Amgen

$177.48

0.08 (0.05%)

LLY

Eli Lilly

$83.83

0.13 (0.16%)

ZSAN

Zosano Pharma

$1.34

0.02 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 19

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Jul

  • 03

    Aug

  • 03

    Aug

  • 03

    Aug

  • 14

    Aug

  • 30

    Aug

  • 11

    Sep

  • 14

    Sep

  • 03

    Feb

TEVA

Teva

$31.95

0.12 (0.38%)

, AGN

Allergan

$245.73

-1.8 (-0.73%)

04:55
07/19/17
07/19
04:55
07/19/17
04:55
Conference/Events
Piper Jaffray specialty pharma analysts hold an analyst/industry conference call »

Specialty Pharmaceuticals…

TEVA

Teva

$31.95

0.12 (0.38%)

AGN

Allergan

$245.73

-1.8 (-0.73%)

SUPN

Supernus

$43.05

1.1 (2.62%)

ALDR

Alder Biopharmaceuticals

$11.55

-0.3 (-2.53%)

AMGN

Amgen

$177.48

0.08 (0.05%)

LLY

Eli Lilly

$83.70

0.06 (0.07%)

ZSAN

Zosano Pharma

$1.34

0.02 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 19

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Jul

  • 03

    Aug

  • 03

    Aug

  • 03

    Aug

  • 14

    Aug

  • 30

    Aug

  • 11

    Sep

  • 14

    Sep

  • 03

    Feb

Monday
SUPN

Supernus

$44.25

0.2 (0.45%)

05:54
07/17/17
07/17
05:54
07/17/17
05:54
Downgrade
Supernus rating change at Piper Jaffray »

Supernus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

Over a week ago
SAFE

Safety, Income and Growth

$19.60

0.06 (0.31%)

, NWSA

News Corp.

$13.23

0.03 (0.23%)

10:30
07/14/17
07/14
10:30
07/14/17
10:30
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

SAFE

Safety, Income and Growth

$19.60

0.06 (0.31%)

NWSA

News Corp.

$13.23

0.03 (0.23%)

WWD

Woodward

$67.48

-0.42 (-0.62%)

CBL

CBL & Associates

$8.64

0.17 (2.01%)

SUPN

Supernus

$44.05

-0.35 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 24

    Jul

  • 04

    Aug

SUPN

Supernus

$44.05

-0.35 (-0.79%)

07:05
07/14/17
07/14
07:05
07/14/17
07:05
Initiation
Supernus initiated at Janney Capital »

Supernus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

TEVA

Teva

$32.25

0.16 (0.50%)

, AGN

Allergan

$243.62

-1.97 (-0.80%)

12:15
07/13/17
07/13
12:15
07/13/17
12:15
Conference/Events
Piper Jaffray specialty pharma analysts hold an analyst/industry conference call »

Specialty Pharmaceuticals…

TEVA

Teva

$32.25

0.16 (0.50%)

AGN

Allergan

$243.62

-1.97 (-0.80%)

SUPN

Supernus

$44.40

0.35 (0.79%)

ALDR

Alder Biopharmaceuticals

$10.13

-2.075 (-17.01%)

AMGN

Amgen

$173.27

-0.05 (-0.03%)

LLY

Eli Lilly

$83.70

0.2035 (0.24%)

ZSAN

Zosano Pharma

$1.31

-0.03 (-2.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 16

    Jul

  • 19

    Jul

  • 19

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Jul

  • 03

    Aug

  • 03

    Aug

  • 14

    Aug

  • 30

    Aug

  • 11

    Sep

  • 14

    Sep

  • 03

    Feb

SUPN

Supernus

$43.60

0.5 (1.16%)

08:18
07/05/17
07/05
08:18
07/05/17
08:18
Recommendations
Supernus analyst commentary at Cantor »

Supernus price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUPN

Supernus

$42.80

-0.4 (-0.93%)

12:16
06/30/17
06/30
12:16
06/30/17
12:16
Conference/Events
Supernus management to meet with SunTrust »

Meeting to be held on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

SUPN

Supernus

$41.85

-2.25 (-5.10%)

05:55
06/28/17
06/28
05:55
06/28/17
05:55
Recommendations
Supernus analyst commentary at Jefferies »

Supernus price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
SUPN

Supernus

$41.40

1.15 (2.86%)

, SHPG

Shire

$167.26

2.21 (1.34%)

12:38
06/21/17
06/21
12:38
06/21/17
12:38
Hot Stocks
Supernus says Shire receives FDA approval for Mydayis for ADHD »

Supernus Pharmaceuticals…

SUPN

Supernus

$41.40

1.15 (2.86%)

SHPG

Shire

$167.26

2.21 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.